- Report
- April 2023
- 112 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- April 2023
- 120 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- October 2022
- 110 Pages
Global
From €4174EUR$4,750USD£3,600GBP
- Report
- March 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- March 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- March 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- January 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- January 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- January 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- January 2024
- 200 Pages
Global
From €3646EUR$4,150USD£3,145GBP
- Report
- October 2023
- 145 Pages
Global
From €2768EUR$3,150USD£2,387GBP
- Report
- October 2023
- 150 Pages
Global
From €2856EUR$3,250USD£2,463GBP
€4262EUR$4,850USD£3,676GBP
- Report
- November 2023
- 178 Pages
Global
From €3361EUR$3,825USD£2,899GBP
€3954EUR$4,500USD£3,411GBP
- Report
- January 2025
- 94 Pages
From €3031EUR$3,450USD£2,615GBP
- Report
- May 2024
- 210 Pages
Global
From €3910EUR$4,450USD£3,373GBP
- Report
- April 2024
- 217 Pages
Global
From €3910EUR$4,450USD£3,373GBP
- Report
- September 2023
- 173 Pages
Global
From €3910EUR$4,450USD£3,373GBP
- Report
- February 2023
- 162 Pages
Global
From €3910EUR$4,450USD£3,373GBP
- Report
- February 2022
- 167 Pages
Global
From €3910EUR$4,450USD£3,373GBP
- Report
- January 2022
- 148 Pages
Global
From €3910EUR$4,450USD£3,373GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more